Citations

Clear

60 citation(s) found for "Scharf, E".

Management of Chronic Subdural Hematoma in Patients Requiring Therapeutic Anticoagulation
Neth, Bryan J. , Ighodaro, Eseosa T. , Brinjikji, Waleed , Cloft, Harry J. , Cloft, Harry, Neth, Byran J. , Scharf, Eugene

Mayo Clinic

The Neurologist | December 2, 2021 | Volume: 27 | Issue: 4 | Pages: 211-213

10.1097/nrl.0000000000000380 | PMID 34855670 Get It

Introduction: A common risk factor of chronic, nontraumatic subdural hematoma (SDH) is anticoagulation therapy. Anticoagulation is generally held in patients who develop SDH, but this can lead to thromboembolic events. While prior studies have reported the clinical outcomes of patients with anticoagulation-related SDH, there remains little evidence regarding ongoing anticoagulation treatment. Case Report: We report the management of 2 patients who developed anticoagulation-related SDH and underwent middle meningeal artery (MMA) embolization and successful reinitiation of anticoagulation therapy. In both patients, we conservatively managed anticoagulation with heparin and/or enoxaparin as a bridge to warfarin after MMA embolization. Follow-up computed tomography head revealed interval decrease of SDH and stable neurological status. Conclusions: These cases provide anecdotal evidence of a challenging clinical scenario where there is a necessary indication for therapeutic anticoagulation (ie, venous sinus thrombosis or atrial appendage thrombus) and comorbid SDH. Endovascular MMA embolization may be an effective adjunct therapy for clinical scenarios in patients with SDH and an urgent indication for anticoagulation. Longer follow-up, prospective series, and future randomized clinical trials are needed to objectively assess outcomes in this clinically challenging patient population.
Impact of Peripheral Microvascular Endothelial Dysfunction on White Matter Hyperintensity
Toya, Takumi , Sara, Jaskanwal Deep Singh , Scharf, Eugene , Ahmad, Ali , Nardi, Valentina , Ӧzcan, Ilke , Lerman, Lilach O. , Lerman, Amir , Sara, Jaskanwal D, Scharf, Eugene L , Ozcan, Ilke , Lerman, Amir , Toya, Takumi , Nardi, Valentina

Mayo Clinic

Journal of the American Heart Association | October 8, 2021 | Volume: 10 | Issue: 20 | Pages: No page available

10.1161/jaha.121.021066 | PMID 34622674 Get It

Background White matter hyperintensity (WMH), characterized by hyperintensities on T2‐weighted fluid‐attenuated inversion recovery brain magnetic resonance imaging, has been linked to an increased risk of ischemic stroke (IS). Endothelial dysfunction is an indicator of vascular dysfunction, predicting the risk of IS. This study aimed to investigate the association between endothelial dysfunction and regional WMH, and its impact on future risk of IS. Methods and Results We enrolled 219 patients (mean age, 53.1±14.1 years; 34.7% men) who underwent peripheral endothelial function assessment using reactive hyperemia peripheral arterial tonometry and brain magnetic resonance imaging without any history of IS. Volumetric WMH segmentation was automatically extrapolated using a validated automated digital tool. Total and juxtacortical WMH volume/intracranial volume (%) increased with aging and became more prominent in patients aged >50 years (n=131) than those aged ≤50 years (n=88) (total WMH: ≤50 years, Pearson r =0.24, P =0.03; >50 years, Pearson r =0.62, P <0.0001; juxtacortical WMH: ≤50 years, Pearson r =0.09, P =0.40; >50 years, Pearson r =0.55, P <0.0001). Reactive hyperemia peripheral arterial tonometry index was negatively associated with total and juxtacortical WMH volume/intracranial volume (%) in patients aged >50 years after adjustment for other covariates (reactive hyperemia peripheral arterial tonometry index, standardized β coefficient −0.17, P =0.04). Juxtacortical WMH volume/intracranial volume (%) was associated with an increased risk of IS during median follow‐up of 6.5 years (hazard ratio, 1.47; 95% CI, 1.05–1.92; P =0.03). Conclusions Peripheral endothelial dysfunction is associated with an increased volume of juxtacortical WMH in patients aged >50 years, which is a potential marker to predict future risk of IS.
CPAP adherence is associated with reduced inpatient utilization among older adult Medicare beneficiaries with pre-existing cardiovascular disease
Bailey, M. Doyinsola , Oldstone, Liesl, Johnson, Abree , Scharf, Steven M. , Albrecht, Jennifer S. , Wickwire, Emerson M. , Somers, Virend K. , Srivastava, Mukta Chandra

Mayo Clinic

Journal of Clinical Sleep Medicine | June 17, 2021 | Volume: 18 | Issue: 1 | Pages: 39-45

10.5664/jcsm.9478 | PMID 34170251 Get It

Endocannabinoid Response in Acute Ischemic Stroke
Buciuc, Marina , Conte, Gian Marco , Scharf, Eugene , Scharf, Eugene L , Buciuc, Marina , Conte, Gian Marco

Mayo Clinic

Stroke | April 8, 2021 | Volume: 52 | Issue: 5 | Pages: No page available

10.1161/strokeaha.121.034131 | PMID 33827241 Get It

CPAP adherence is associated with reduced risk for stroke among older adult Medicare beneficiaries with obstructive sleep apnea
Bailey, M. Doyinsola , Scharf, Steven M. , Johnson, Abree , Albrecht, Jennifer S. , Wickwire, Emerson M. , Somers, Virend K. , Srivastava, Mukta Chandra

Mayo Clinic

Journal of Clinical Sleep Medicine | February 22, 2021 | Volume: 17 | Issue: 6 | Pages: 1249-1255

10.5664/jcsm.9176 | PMID 33612161 Get It

Left-sided carotid arteries have a higher prevalence of intraplaque hemorrhage than right-sided: An asymmetric conundrum
Larson, Anthony S. , Brinjikji, Waleed , Savastano, Luis , Benson, John C. , Larson, Anthony , Scharf, Eugene , Huston, John

Mayo Clinic

The Neuroradiology Journal | December 5, 2020 | Volume: 33 | Issue: 6 | Pages: 494-500

10.1177/1971400920970920 | PMID 33283672 Get It

Purpose To assess whether an asymmetry exists in the prevalence of carotid artery intraplaque hemorrhage (IPH) between right- and left-sided arteries. Materials and methods The records of all patients with atherosclerotic carotid artery disease that underwent neck magnetic resonance angiography imaging with high-resolution plaque sequences between 2017 and 2020 at our institution were retrospectively reviewed. The prevalence of stenosis and IPH was determined for all patients and compared between the left and right carotid arteries of those with unilateral anterior circulation ischemic strokes. Multiple regression analysis was performed to determine potential independent associations of IPH laterality with ischemic strokes. Results A total of 368 patients were included overall and 241 were male (65.4%). There were a total of 125 asymptomatic patients and 211 patients with unilateral anterior circulation ischemic strokes. Of patients with ischemic strokes, 55.5% had left-sided strokes compared with 44.5% who had right-sided strokes ( p = 0.03). Patients with left-sided strokes had a higher prevalence of ipsilateral IPH than those with right-sided strokes (64.1% versus 36.2%, p < 0.0001), despite similar degrees of stenosis. Both age (odds ratio (OR): 1.0; 95% confidence interval (CI): 1.0–1.1; p = 0.007) and the presence of left-sided IPH (OR: 3.2; 95% CI: 1.5–6.8; p = 0.003) were independently associated with unilateral ischemic strokes. Conclusions Left-sided plaques more frequently have IPH and may be more likely to result in ipsilateral ischemic strokes compared with right-sided plaques. The underlying mechanism of asymmetric distribution of IPH between right and left carotids remains unclear.
Zoster vasculopathy surveillance using intracranial vessel wall imaging
English, Stephen , Carabenciov, Ivan D. , Petty, George W., English, Stephen W, Lehman, Vance T. , Scharf, Eugene

Mayo Clinic

Neurology Clinical Practice | December 10, 2019 | Volume: 9 | Issue: 6 | Pages: 462-464

10.1212/cpj.0000000000000626 | PMID 32042478 Get It

First-Line Prescribing Preferences of American Hematology-Oncology Physicians for Patients with CLL: Impact of Age, Co-Morbidities, and Tempo of Disease
Green, Mark R., Williams, Michael E. , Willey, Joanne, Scharf, Mitchell, Neely, Douglas, Foran, James M. , Heckman, Michael G.

Mayo Clinic

Blood | October 14, 2019 | Volume: 120 | Issue: 21 | Pages: 4608-4608

10.1182/blood.v120.21.4608.4608 Get It

Abstract Abstract 4608 Background: FCR has been a preferred 1st line therapy approach in CLL for the past decade. However it is associated with substantial toxicity and not recommended in NCCN guidelines for patients over age 70. We studied the impact of age, co-morbidities, and tempo of disease on 1st line therapy prescribing preferences of American hematology-oncology physicians (AHOP) for patients with CLL. Methods: During Feb-March 2012, prescribing preferences of 325 individual AHOP were assessed using a proprietary, live, case-based market research tool (Challenging Cases™). A core case scenario was constructed with variations based on altered age, co-morbidities, and tempo of disease progression prior to initial therapy. Preference data were acquired using blinded audience response technology. Responses for each scenario were obtained prior to any display of participant selections. All sources of research support were blinded. Core scenario: 67y male; CD 38+, ZAP 70+, del 13q and del 11q CLL, adenopathy, lymphocytosis, splenomegaly, anemia (Hgb 9.5 gm) but no thrombocytopenia. Co-morbidities: medication-controlled hypertension, moderate restrictive airways disease, and type 2 diabetes managed with metformin. Modified scenario: same clinical presentation except the patient is 72 years of age. Slower tempo of disease scenario: age 68y, time frame of observation without treatment 3 years from diagnosis, now with disease progression, anemia 10.9 gms, FISH only del 13q. Results: A progressive decrease in preference for FCR and commensurate rise in preference for BR as first line therapy occurs as age increases and co-morbidities are present (p<0.001). See table 1 Conclusion: As age crosses the 70 year threshold and as co-morbidities complicate therapy, there is a statistically significant increase in preference among AHOPs for prescribing bendamustine-rituximab as initial management for patients with RAI stage III CLL. Disclosures: Green: Xcenda: Employment; Teva: Consultancy, ownes publically traded shares in Teva Pharmaceuticals through 3rd party investment advisors, ownes publically traded shares in Teva Pharmaceuticals through 3rd party investment advisors Other. Williams:Xcenda: Honoraria. Willey:Xcenda: Employment. Scharf:Xcenda: Employment. Neely:xcenda: Employment. Foran:Xcenda: Honoraria.
Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity
Graff‐Radford, Jonathan , Przybelski, Scott A. , Lesnick, Timothy G. , Preboske, Gregory M., Senjem, Matthew L. , Gunter, Jeffrey L. , Kantarci, Kejal , Petersen, Ronald C. , Jack, Clifford R. , Vemuri, Prashanthi , Jack, Clifford R , Vemuri, Prashanthi , Senjem, Matthew L , Kantarci, Kejal , Scharf, Eugene , Mielke, Michelle M. , Knopman, David S. , Schwarz, Christopher G. , Machulda, Mary M.

Mayo Clinic

Stroke | September 12, 2019 | Volume: 50 | Issue: 11 | Pages: 3037-3044

10.1161/strokeaha.119.025822 | PMID 31510903 Get It

Background and Purpose— White matter hyperintensity (WMH) burden is associated with stroke and cognitive decline. Risk factors associated with the longitudinal progression of WMH in the general population have not been systematically investigated. To investigate the primary midlife and current cardiometabolic risk factors associated with changes in WMH over time in a population cohort. Methods— This cohort study included participants enrolled in the Mayo Clinic Study of Aging, a longitudinal population-based study in Olmsted County, Minnesota with at least 2 consecutive WMH assessments on fluid-attenuated inversion recovery-magnetic resonance images (n=554, ≥60 years with midlife assessments) with relevant baseline laboratory measures of interest. Linear mixed model regression was used to determine the important components of cardiometabolic risk profile at baseline that were associated with future progression of WMH. These analyses were controlled for age and sex. Sensitivity analyses were conducted using stratification by sex. The main outcome measure was percent change in WMH normalized to total intracranial volume. Three sets of models were constructed to evaluate individual (1) midlife risk factors, (2) current risk factors including the presence of metabolic syndrome and its constituents, and (3) baseline measurements of continuous laboratory measures of cardiometabolic risk. Results— Age was the strongest predictor of progression in WMH ( P <0.001). Baseline hypertension ( P <0.001), midlife hypertension ( P =0.003), and baseline fasting glucose in males ( P =0.01) were predictive of WMH change. The presence of metabolic syndrome was not associated with progressive WMH. In sensitivity analyses, associations between hypertension and WMH progression were stronger in females. Baseline serum glucose was associated with increase in WMH but was not significant in females in the stratified analysis. Other continuous laboratory measures of vascular risk were not associated with progressive WMH. Conclusions— Midlife and current hypertension in all participants and fasting glucose in males were associated with quantitative changes in white matter. Prospective clinical studies should determine optimal blood pressure to reduce stroke and cognitive impairment during aging.
Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG
Honorat, Josephe A., López‐Chiriboga, A. Sebastian , Kryzer, Thomas J., Komorowski, Lars , Scharf, Madeleine, Hinson, Shannon R., Lennon, Vanda A. , Pittock, Sean J. , Pittock, S J , Klein, Christopher J. , McKeon, Andrew

Mayo Clinic

Neurology | August 2, 2019 | Volume: 93 | Issue: 10 | Pages: No page available

10.1212/wnl.0000000000008061 | PMID 31371564 Get It